Pathogen vaccination, nanoparticles (polyhydroxylated fullerenols), galectin-9, GM-CSF, and inhibiting melanoma suppression of macrophage movement by macrophage inhibitory cytokines are some immunomodulatory agents that can be used to achieve this goal [130]. The gene discussed is CSF2; the disease is melanoma.